The interaction of Aβ with RAGE is critical for the pathology of AD and is a promising target for the development of therapy, since disruption of this complex can be achieved with the help of therapeutic substances circulating in the bloodstream [15]. The gene discussed is AGER; the disease is Alzheimer disease.